Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252.SS)
- Previous Close
2.2500 - Open
2.2400 - Bid 2.2300 x --
- Ask 2.2400 x --
- Day's Range
2.2100 - 2.2600 - 52 Week Range
1.9000 - 2.7900 - Volume
16,956,960 - Avg. Volume
32,626,248 - Market Cap (intraday)
7.731B - Beta (5Y Monthly) 0.39
- PE Ratio (TTM)
112.00 - EPS (TTM)
0.0200 - Earnings Date --
- Forward Dividend & Yield 0.01 (0.44%)
- Ex-Dividend Date Jun 9, 2023
- 1y Target Est
--
Guangxi Wuzhou Zhongheng Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals in China. The company offers xueshuantong for injection, zhonghua dieda pills, fuyanjing capsules, jieshitong tablets, yanjianning tablets, angong niuhuang pills, shedan chuanbei liquid, and fluorescein sodium injection covers range of therapeutic areas, such as cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and other fields. It also provides toothpaste, mouthwash, mouth spray, laundry detergents, laundry beads, shower gels, Shampoos, electric toothbrush, tooth rinser, electric toothpaste, and other series of products under the Tianqi, Tianqi Doll, and Pure Cotton Era brands; and medical instruments, including mask series, protective clothing, isolation eye masks, and forehead thermometers, as well as Chinese herbal medicines. In addition, the company produces health food products under the DOUBLE MONEY brand. Additionally, it engages in the real estate development and management, and project investment. The company was founded in 1993 and is headquartered in Wuzhou, China.
www.wz-zhongheng.com2,886
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 600252.SS
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600252.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600252.SS
Valuation Measures
Market Cap
7.77B
Enterprise Value
5.96B
Trailing P/E
91.46
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.49
Price/Book (mrq)
1.18
Enterprise Value/Revenue
1.93
Enterprise Value/EBITDA
17.40
Financial Highlights
Profitability and Income Statement
Profit Margin
2.72%
Return on Assets (ttm)
-0.01%
Return on Equity (ttm)
0.37%
Revenue (ttm)
3.1B
Net Income Avi to Common (ttm)
84.31M
Diluted EPS (ttm)
0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
4.09B
Total Debt/Equity (mrq)
21.57%
Levered Free Cash Flow (ttm)
-52.41M
Company Insights: 600252.SS
600252.SS does not have Company Insights